SAB Biotherapeutics
Eddie J. Sullivan is President & CEO at SAB Biotherapeutics, Inc.Previously, Eddie was President at South Dakota Biotechnology Assocation, and was Vice President of Business Development and Government Relations at Sanford Applied Biosciences. Eddie went to
Brigham Young University and Utah State University.
This person is not in any offices
SAB Biotherapeutics
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.